Top
OR5L2 has not been detected as a mutational cancer driver

OR5L2
Ensembl id ENSG00000205030
Mutated samples
Coding Sequence 120 (1.8%)
Protein Affecting 83 (1.2%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all OR5L2 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Lung adenocarcinoma No 21 17 4.35
Lung squamous cell carcinoma No 13 11 6.32
Head and neck squamous cell carcinoma No 13 10 2.67
Cutaneous melanoma No 28 9 2.44
Esophageal carcinoma No 9 8 5.48
Small cell lung carcinoma No 8 6 8.70
Bladder carcinoma No 4 4 4.08
Stomach adenocarcinoma No 5 4 2.48
Prostate adenocarcinoma No 3 3 1.23
Breast carcinoma No 4 3 0.26
Glioblastoma multiforme No 4 3 0.79
Thyroid carcinoma No 1 1 0.31
Neuroblastoma No 1 1 0.48
Chronic lymphocytic leukemia No 3 1 0.34
Lower grade glioma No 1 1 0.59
Serous ovarian adenocarcinoma No 1 1 0.32
Multiple myeloma No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence